KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) R&D In Process: 2013-2014

Historic R&D In Process for Sarepta Therapeutics (SRPT) over the last 1 years, with Mar 2014 value amounting to $29.5 million.

  • Sarepta Therapeutics' R&D In Process was N/A to $29.5 million in Q1 2014 from the same period last year, while for Mar 2014 it was $117.8 million, marking a year-over-year change of. This contributed to the annual value of $173.2 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q1 2014, Sarepta Therapeutics' R&D In Process is $29.5 million, which was down 0.00% from $29.5 million recorded in Q4 2013.
  • Sarepta Therapeutics' R&D In Process' 5-year high stood at $29.5 million during Q2 2013, with a 5-year trough of $29.5 million in Q2 2013.
  • Moreover, its 2-year median value for R&D In Process was $29.5 million (2014), whereas its average is $29.5 million.